Target intelligence / Profile preview

Filamin-A-interacting protein 1 (FILIP1)

Target
FILIP1
Molecular classification
Actin-binding protein, Cytoskeletal regulator, Other (not a receptor, enzyme, channel, transporter, or transcription factor)
01

Overview

Filamin-A-interacting protein 1 (FILIP1) is an actin-binding cytoskeletal regulatory protein encoded by the FILIP1 gene[4][5][6]. It binds filamin A and stimulates its degradation, which in turn regulates cytoskeletal structure essential for cell migration, particularly in the developing neocortex[1][3][5][6]. FILIP1 helps control neuronal polarity and the transition between multipolar and bipolar cell shapes, thus supporting proper arrangement and migration of neurons during brain development[1][3]. In muscle cells, FILIP1 functions as a dual-compartment protein, linking microtubules to myofibrils and helping assemble and stabilize these structures during differentiation; it also protects muscle cells from mechanical stress-induced damage[2]. Beyond the nervous system and muscle, FILIP1 expression and function have been implicated in various pathological conditions, including neurodevelopmental disorders, ulcerative colitis, and several cancers, where its altered expression correlates with prognosis or chemoresistance[1][5]. FILIP1 is not typically classified as a therapeutic target, and no drugs are known to interact with it directly[5][6].

Other names
FILIP1Filamin-A-interacting protein 1KIAA1275FILIPNMDFFLIP1
02

Mechanism of action

Not applicable; no drugs target FILIP1 directly. FILIP1 itself modulates protein degradation, migration, and cytoskeletal dynamics

03

Biological functions

Regulation of cytoskeletal dynamics by binding filamin A and promoting its degradationRegulation of cortical neuron migration and dendritic spine morphologyModulation of neuronal polarity and migration during brain developmentAssociation with myofibril and microtubule assembly during muscle differentiation; protects muscle cells from mechanical stressCell adhesion and motility modulation via Rho GTPase signaling network
04

Disease associations

Neurodevelopmental disorders (including intellectual disability and migration defects)Neuromuscular disorders, congenitalUlcerative colitis and cancer (expression changes in cancer types such as gastric, ovarian, lung)Muscle differentiation disorders

Beyond the preview

Go deeper on Filamin-A-interacting protein 1 (FILIP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Filamin-A-interacting protein 1 (FILIP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call